T1	Participants 344 397	patients with C. difficile-associated diarrhea (CDAD)
T2	Participants 87 108	Clostridium difficile
T3	Participants 779 800	77 patients with CDAD
T4	Participants 1068 1086	patients with CDAD
T5	Participants 1183 1204	individuals with CDAD
